We are live on ! Find out more
ST

SAL Trading Portfolio holdings

AUM $57M
1-Year Est. Return 33.89%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+33.89%
3 Year Est. Return
+18.85%
5 Year Est. Return
10 Year Est. Return
AUM
$57M
AUM Growth
-$1.19M
Cap. Flow
-$4.21M
Cap. Flow %
-7.38%
Top 10 Hldgs %
100%
Holding
17
New
5
Increased
1
Reduced
1
Closed
8

Top Buys

Rank Stock Value
1
RIO icon
Rio Tinto
RIO
+$718K
2
FRO icon
Frontline
FRO
+$558K
3
MT icon
ArcelorMittal
MT
+$451K

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.14M
2
BTI icon
British American Tobacco
BTI
+$924K
3
BP icon
BP
BP
+$848K
4
RACE icon
Ferrari
RACE
+$613K
5
CMBT
CMB.TECH NV
CMBT
+$187K

Sector Composition

Rank Sector Weight
1 Materials 2.3%
2 Healthcare 1.85%
3 Energy 0.95%
4 Consumer Discretionary 0%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$775B
$47M 82.43%
81,899
GSK icon
2
CALL
GSK
GSK
$107B
$4.06M 7.12%
+99,300
New +$4.06M
GSK icon
3
PUT
GSK
GSK
$107B
$2.07M 3.63%
+50,600
New +$2.07M
ARGX icon
4
argenx
ARGX
$55.2B
$1.06M 1.85%
1,949
RIO icon
5
Rio Tinto
RIO
$150B
$796K 1.4%
+11,185
New +$718K
ARGX icon
6
CALL
argenx
ARGX
$55.2B
$705K 1.24%
1,300
+800
+160% +$404K
FRO icon
7
Frontline
FRO
$8.63B
$542K 0.95%
+23,700
New +$558K
MT icon
8
ArcelorMittal
MT
$49.1B
$517K 0.91%
+19,700
New +$451K
ARGX icon
9
PUT
argenx
ARGX
$55.2B
$271K 0.48%
500
-1,600
-76% -$809K
AZN icon
10
AstraZeneca
AZN
$271B
-39,351
Closed -$6.14M
BHP icon
11
CALL
BHP
BHP
$209B
-15,100
Closed -$862K
BHP icon
12
PUT
BHP
BHP
$209B
-22,200
Closed -$1.27M
BP icon
13
BP
BP
$112B
-23,500
Closed -$848K
BTI icon
14
British American Tobacco
BTI
$136B
-29,869
Closed -$924K
RACE icon
15
Ferrari
RACE
$68B
-1,500
Closed -$613K
RIO icon
16
CALL
Rio Tinto
RIO
$150B
-12,500
Closed -$824K
CMBT
17
CMB.TECH NV
CMBT
$4.53B
-11,300
Closed -$187K

Similar funds

SAL Trading's Q3 2024 Portfolio in Review

As of Q3 2024, SAL Trading held 17 positions worth $57M, down 2% from $58.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SAL Trading withdrew a net $4.21M in Q3 2024, closing 8 positions and reducing 1 holding. Its most notable exit was AstraZeneca, an estimated $6.14M position sold in full.

By sector, the portfolio is most concentrated in Materials at 2.3% of assets, followed by Healthcare and Energy.

Against the trend, SAL Trading opened a new position in Rio Tinto worth $796K.

  • SAL Trading's largest Q3 2024 buy was Rio Tinto: 11,185 shares worth $796K.
  • SAL Trading fully exited AstraZeneca in Q3 2024, selling an estimated $6.14M.
  • SAL Trading's ten largest holdings make up 100% of its $57M portfolio in Q3 2024.
  • SAL Trading opened 5 new positions and closed 8 in Q3 2024.
  • SAL Trading's portfolio value fell 2% quarter-over-quarter to $57M.

Based on SAL Trading's 13F filing for Q3 2024, filed 14 Nov 2024.